| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $53.41 ▲ +1.33% | Yesterday | $52.42 ▼ -0.56% | Tomorrow's Monopar Therapeutics Inc. Common Stock (MNPR) setup is anchored to $52.71 and targets $53.41 (+1.33%). The near-term read is upside; watch $54.29 / $51.13 because daily realized volatility is about 6.84%. |
Tomorrow's Monopar Therapeutics Inc. Common Stock (MNPR) setup is anchored to $52.71 and targets $53.41 (+1.33%). The near-term read is upside; watch $54.29 / $51.13 because daily realized volatility is about 6.84%. | ||||
| Week | $54.88 ▲ +4.12% | Last Week | $51.80 ▼ -1.73% | The 7-day Monopar Therapeutics Inc. Common Stock model moves from $51.80 to $54.88 (+4.12%). It gives upside momentum context for this stock, so breaks around $54.29 / $51.13 matter more than a single tick. |
The 7-day Monopar Therapeutics Inc. Common Stock model moves from $51.80 to $54.88 (+4.12%). It gives upside momentum context for this stock, so breaks around $54.29 / $51.13 matter more than a single tick. | ||||
| Month | $57.34 ▲ +8.79% | Last Month | $50.77 ▼ -3.69% | The 1-month Monopar Therapeutics Inc. Common Stock target is $57.34 (+8.79%), compared with the live reference near $52.71. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Monopar Therapeutics Inc. Common Stock target is $57.34 (+8.79%), compared with the live reference near $52.71. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $61.02 ▲ +15.77% | Last Year | $49.22 ▼ -6.62% | The 1-year Monopar Therapeutics Inc. Common Stock scenario points to $61.02 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Monopar Therapeutics Inc. Common Stock scenario points to $61.02 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $69.65 ▲ +32.14% | 5 Years Ago | $45.59 ▼ -13.50% | The 5-year Monopar Therapeutics Inc. Common Stock view is $69.65 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Monopar Therapeutics Inc. Common Stock view is $69.65 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $52.71 | Mid |
| Daily Change | -3.64% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $52.71 | Daily Change | -3.64% |
| Market Cap | $352.74M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.